Literature DB >> 16445789

Hereditary angio-oedema with normal C1 inhibitor in a family with affected women and men.

K Bork1, D Gül, G Dewald.   

Abstract

Recurrent angio-oedema is a sign of various acquired and inherited disease entities, including hereditary angio-oedema types I and II that result from a genetic deficiency of C1 inhibitor, and a recently described type of dominantly inherited angio-oedema, which does not show a deficiency of C1 inhibitor. Until now, this new type of hereditary angio-oedema, designated as hereditary angio-oedema type III, has been assumed to be a disorder specific to females. We now describe a four-generation family with dominantly inherited angio-oedema and normal C1 inhibitor in which, in contrast to all previous observations, not only five female but also three male family members were clinically affected. One male patient was mainly affected following the intake of angiotensin-converting enzyme inhibitors. Our current observation leads to new considerations about the classification of hereditary angio-oedema with normal C1 inhibitor. Either hereditary angio-oedema with normal C1 inhibitor can be an entity affecting females predominantly, but not exclusively; in that case, men appear to have a much reduced chance of clinical manifestations. Alternatively, our present observation of hereditary angio-oedema with normal C1 inhibitor affecting both sexes may represent a new disease entity, presumably with a different underlying defect.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16445789     DOI: 10.1111/j.1365-2133.2005.07048.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  15 in total

Review 1.  Wolf in the sheep's clothing: intestinal angioedema mimicking infectious colitis.

Authors:  Asif Mehmood; Hafez Mohammad Ammar Abdullah; Faisal Inayat; Waqas Ullah
Journal:  BMJ Case Rep       Date:  2018-12-13

Review 2.  Hereditary angioedema in childhood: an approach to management.

Authors:  Didier G Ebo; Marjoke M Verweij; Kathleen J De Knop; Margo M Hagendorens; Chris H Bridts; Luc S De Clerck; Wim J Stevens
Journal:  Paediatr Drugs       Date:  2010-08-01       Impact factor: 3.022

3.  Increased activity of coagulation factor XII (Hageman factor) causes hereditary angioedema type III.

Authors:  Sven Cichon; Ludovic Martin; Hans Christian Hennies; Felicitas Müller; Karen Van Driessche; Anna Karpushova; Wim Stevens; Roberto Colombo; Thomas Renné; Christian Drouet; Konrad Bork; Markus M Nöthen
Journal:  Am J Hum Genet       Date:  2006-10-18       Impact factor: 11.025

4.  Factor XII mutations, estrogen-dependent inherited angioedema, and related conditions.

Authors:  Karen E Binkley
Journal:  Allergy Asthma Clin Immunol       Date:  2010-07-28       Impact factor: 3.406

Review 5.  [Angioedema].

Authors:  H F Merk
Journal:  Hautarzt       Date:  2007-12       Impact factor: 0.751

Review 6.  Clinical Immunology Review Series: An approach to the patient with angio-oedema.

Authors:  S Grigoriadou; H J Longhurst
Journal:  Clin Exp Immunol       Date:  2009-03       Impact factor: 4.330

7.  Hereditary angioedema with normal c1 inhibition.

Authors:  Konrad Bork
Journal:  Curr Allergy Asthma Rep       Date:  2009-07       Impact factor: 4.806

Review 8.  Angioedema with normal laboratory values: the next step.

Authors:  Janelle Sher; Mark Davis-Lorton
Journal:  Curr Allergy Asthma Rep       Date:  2013-10       Impact factor: 4.806

Review 9.  Leveraging Genetics for Hereditary Angioedema: A Road Map to Precision Medicine.

Authors:  Anastasios E Germenis; Matija Rijavec; Camila Lopes Veronez
Journal:  Clin Rev Allergy Immunol       Date:  2021-01-28       Impact factor: 8.667

10.  Obstetrical Complications and Outcome in Two Families with Hereditary Angioedema due to Mutation in the F12 Gene.

Authors:  Olivier Picone; Anne-Claire Donnadieu; François G Brivet; Catherine Boyer-Neumann; Véronique Frémeaux-Bacchi; René Frydman
Journal:  Obstet Gynecol Int       Date:  2010-05-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.